Answer:
The lymphatic system is a complex system of fluid drainage and transport, and immune response and disease resistance. Fluid that is forced out of the bloodstream during normal circulation is filtered through lymph nodes to remove bacteria, abnormal cells and other matter.
lymph circulation. The flow of lymph from the tissues into the lymphatic collecting system. ... It is collected into lymph capillaries, which carry the lymph to the larger lymph vessels. These converge to form one of two main trunks, the right lymphatic duct and the thoracic duct.
Understanding the lymphatic system's role in immune cell trafficking and immune responses, contribution to fat transport, distribution, metabolism and implication in the pathogenesis of chronic intestinal inflammation may provide the basis for new therapeutic strategies and improved quality-of life.
HOPE IT HELPS : D
Explanation:
Answer:
they release substances
Explanation:
also known as inflammatory mediators
Answer:
Explanation:
Causes of hypocalcemia (calcium deficiency):
- Menopause
- Low levels of vitamin D
- hormonal imbalances (removal/overactivation of parathyroid)
- renal failures
Symptoms of hypocalcemia:
- Memory loss or confusion
- muscle spasms
- numbness/tingling in the extremities (hands, feet, face)
- brittle nails
- more prone to fractures
Answer:
The answer is reciprocal chromosomal translocation
Explanation:
The Philadelphia chromosome (Ph) is the truncated chromosome 22 generated by the reciprocal translocation t(9;22)(q34;q11) and was first identified in 1960 in a patient with CML [3]. Translocation of the proto-oncogene tyrosine-protein kinase (ABL1) gene located on chromosome 9 to the breakpoint cluster region (BCR) gene located on chromosome 22 results in a BCR-ABL1 fusion gene on the Ph [4, 5]. Three BCR-ABL1 fusion gene hybrids encode BCR-ABL1 protein isoforms p210, p190, and p230, which have persistently enhanced tyrosine kinase (TK) activity. These aberrantly activated kinases disturb downstream signaling pathways, causing enhanced proliferation, differentiation arrest, and resistance to cell death [6, 7]. Tyrosine kinase inhibitors (TKIs) targeting the BCR-ABL1 protein are the most successful targeted therapy for Ph-positive leukemia.
Answer:
Potassium Feldspar
Explanation:
Got the answer after a lot of research.
